CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 11 filers reported holding CAN-FITE BIOPHARMA LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $471,000 | -53.1% | 538,600 | -32.4% | 0.31% | -53.8% |
| Q4 2018 | $1,004,000 | -2.2% | 796,500 | 0.0% | 0.66% | +41.5% |
| Q3 2018 | $1,027,000 | +9.3% | 796,500 | 0.0% | 0.47% | +8.0% |
| Q2 2018 | $940,000 | -11.3% | 796,500 | 0.0% | 0.44% | -4.4% |
| Q1 2018 | $1,060,000 | -10.5% | 796,500 | 0.0% | 0.46% | +9.9% |
| Q4 2017 | $1,185,000 | -12.0% | 796,500 | 0.0% | 0.41% | -4.6% |
| Q3 2017 | $1,346,000 | -6.1% | 796,500 | 0.0% | 0.43% | -8.6% |
| Q2 2017 | $1,434,000 | -6.2% | 796,500 | 0.0% | 0.48% | +6.0% |
| Q1 2017 | $1,529,000 | -19.3% | 796,500 | 0.0% | 0.45% | -19.0% |
| Q4 2016 | $1,895,000 | -10.2% | 796,500 | 0.0% | 0.55% | -10.7% |
| Q3 2016 | $2,111,000 | +31.0% | 796,500 | +26.3% | 0.62% | +34.6% |
| Q2 2016 | $1,611,000 | +4.4% | 630,500 | +14.0% | 0.46% | +15.0% |
| Q1 2016 | $1,543,000 | -6.9% | 553,100 | -2.6% | 0.40% | +0.3% |
| Q4 2015 | $1,658,000 | -17.7% | 568,000 | +16.8% | 0.40% | -6.1% |
| Q3 2015 | $2,014,000 | +164.0% | 486,500 | +39.6% | 0.42% | +205.8% |
| Q2 2015 | $763,000 | +1716.7% | 348,500 | +1743.9% | 0.14% | +1885.7% |
| Q1 2015 | $42,000 | – | 18,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TAYLOR ASSET MANAGEMENT INC | 796,500 | $2,111,000 | 0.62% |
| MENTA CAPITAL LLC | 43,832 | $115,000 | 0.01% |
| MORGAN STANLEY | 5,400 | $14,000 | 0.00% |
| UBS Group AG | 204 | $1,000 | 0.00% |
| IFP Advisors, Inc | 1,000 | $3,000 | 0.00% |
| Advisor Group, Inc. | 4,000 | $10,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,048 | $5,000 | 0.00% |